Interactions between von Willebrand factor and Factor VIII: where did they first meet

J Pediatr Hematol Oncol. 2000 May-Jun;22(3):269-75. doi: 10.1097/00043426-200005000-00017.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Cattle
  • Chromosomes, Human, Pair 12 / genetics
  • Cytoplasmic Granules / metabolism
  • Deamino Arginine Vasopressin / pharmacology
  • Deamino Arginine Vasopressin / therapeutic use
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Extracellular Matrix / metabolism
  • Factor VIII / genetics
  • Factor VIII / metabolism*
  • Factor VIII / therapeutic use
  • Female
  • Genetic Therapy
  • Genotype
  • Hemophilia A / genetics
  • Hemophilia A / therapy
  • Humans
  • Macromolecular Substances
  • Male
  • Mice
  • Models, Biological
  • Pituitary Neoplasms / pathology
  • Platelet Adhesiveness / physiology
  • Protein Binding
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / therapeutic use
  • Transfection
  • Tumor Cells, Cultured
  • X Chromosome / genetics
  • von Willebrand Diseases / classification
  • von Willebrand Diseases / genetics
  • von Willebrand Diseases / therapy
  • von Willebrand Factor / genetics
  • von Willebrand Factor / metabolism*
  • von Willebrand Factor / therapeutic use

Substances

  • Macromolecular Substances
  • Recombinant Fusion Proteins
  • von Willebrand Factor
  • Factor VIII
  • Deamino Arginine Vasopressin